Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-19T01:53:51.564Z Has data issue: false hasContentIssue false
  • English
  • Français

Conflict over Conflicts of Interest: An Analysis of the New NIH Rules

Published online by Cambridge University Press:  01 January 2021

Jennifer L. Gold
Get access Rights & Permissions [Opens in a new window]

Extract

Increasing reports of financial entanglements involving scientist and industry have led some to question the neutrality of research results. In December 2003, a story in the Los Angeles Times shocked readers by exposing several cases of NIH scientists embroiled in serious financial conflicts of interest.1 It was revealed, for example, that senior NIH official Stephen Katz was a paid consultant to Schering AG, a German pharmaceutical company with which he was involved in conducting clinical trials. In a similar case, John Gallin, director of the NIH's Clinical Center, was discovered to have co-authored an article on a company's gene-transfer technology, while being paid as a consultant to a subsidiary of the same company. Jeffrey Schlom, director of the National Cancer Institute's Laboratory of Tumor Immunology and Biology, helped direct NIH-funded studies examining wider use for a particular cancer drug while serving as a consultant whose highest-paying client was looking to genetically engineer that drug.

Type
Independent
Information
Journal of Law, Medicine & Ethics , Volume 34 , Issue 1 , Spring 2006 , pp. 105 - 110
Copyright
Copyright © American Society of Law, Medicine and Ethics 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Willman, D., “Stealth Merger: Drug Companies and Government Medical Research,” L. A. Times, December 7, 2003, at A1.Google Scholar
Abramson, J., Overdosed America: The Broken Promise of American Medicine (New York: Harper Collins, 2005).Google Scholar
Kohl, S. S., Rose and Podolsky Law Offices, Gelsinger v. Trustees of the University of Pennsylvania (Phila. Cnty. Ct. of C.P. filed September 18, 2000): 2000. A viral vector is viral DNA that has been modified to serve as a means of delivering the genetically engineered DNA to the patient.Google Scholar
Miller, F. H., “Trusting Doctors: Tricky Business when it comes to Clinical Research,” Boston University Law Review 81 (2001): 423–443.Google Scholar
Steinbrook, R., “Financial Conflicts of Interest and the NIH,” New England Journal of Medicine 350, no. 4 (2004): 327–30.CrossRefGoogle Scholar
Labrador, D., “Damage Control,” Scientific American 291, no. 5 (2004): 18–20, at 18.Google Scholar
Kaiser, J., “Conflict of Interest: NIH Proposes Temporary Ban on Paid Consulting,” Science 306, no. 5693 (2004): at 27.Google Scholar
Kaiser, J., “Conflict of Interest: NIH Chief Clamps Down on Consulting and Stock Ownership,” Science 307, no. 5711 (2005): 824–5.Google Scholar
Summary of NIH-Specific Provisions in Interim Final Rule, available at <www.nih.gov/about/ethics/020105COIsummary.pdf> (last visited January 13, 2006).+(last+visited+January+13,+2006).>Google Scholar
Wysocki, B., “Some Scientists Say New Ethics Rules May Damage NIH,” Wall Street Journal, March 3, 2005, at B1.Google Scholar
Wadman, M., “NIH Workers see Red over Revised Rules for Conflicts of Interest,” Nature 434, no. 7029 (2005): 3–4.Google Scholar
See Wadman, , supra note 11.Google Scholar
Kaiser, J., “Conflict-of-Interest Policy: NIH Rules Make Some Pack, Others Plead,” Science 307, no. 5716 (2005): 1703.Google Scholar
Rosenwald, M. S. and Weiss, R., “New Ethics Rules Cost NIH Another Top Researcher,” Washington Post, April 2, 2005, at A1.Google Scholar
See Wadman, , supra note 11.Google Scholar
Weiss, R., “NIH Clears Most Researchers in Conflict-of-Interest Probe,” Washington Post, February 23, 2005, at A1.Google Scholar
Kaiser, J., “NIH Ethics: Staff Scientists Protest Plan to Ban Outside Fees,” Science 306, no. 5700 (2004): 1276.Google Scholar
Administration News, “Some NIH Scientists Hire Law Firm to Fight Against New Conflict of Interest Rules,” Kaiser Daily Health Policy Report April 2, 2005, available at <http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=3&DR_ID=29506> (last visited January 13, 2006).+(last+visited+January+13,+2006).>Google Scholar
5 U.S.C. 553(b)-(c).Google Scholar
Department of Health and Human Services, “Supplemental Standards of Ethical Conduct and Financial Disclosure Requirements for Employees of the Department of Health and Human Services,” Federal Register 70, no. 22 (2005): 5543–5565. From the Federal Register, available at <http://a257.g.akamaitech.net/7/257/2422/01jan20051800/edocket.access.gpo.gov/2005/pdf/05-2029.pdf> (last visited January 13, 2006).+(last+visited+January+13,+2006).>Google Scholar
Croley, S. P., “Symposium on the 50th Anniversary of the APA: The Administrative Procedures Act and Regulatory Reform: A Reconciliation,” Administrative Law Journal of American University 10 (1996): 35–49.Google Scholar
415 U.S 199 (1974).Google Scholar
See supra note 22.Google Scholar
486 F.2d 375 (D.C. Cir. 1973).Google Scholar
568 F.2d 240 (2d Cir. 1977).Google Scholar
See Department of Health and Human Services, supra note 20.Google Scholar
See Weiss, , supra note 16.Google Scholar
See Weiss, , supra note 16.Google Scholar
Finkelstein, J. B., “Doctors Warned about October's HIPAA Deadline,” American Medical News May 19, 2003, at <http://www.ama-assn.org/amednews/2003/05/19/gvsa0519.htm> (last visited January 13, 2006). (last visited January 13, 2006).' href=https://scholar.google.com/scholar?q=Finkelstein,+J.+B.,+“Doctors+Warned+about+October's+HIPAA+Deadline,”+American+Medical+News+May+19,+2003,+at++(last+visited+January+13,+2006).>Google Scholar
See Wysocki, , supra note 10.Google Scholar
Dornbrand, L. Dubler, N. N., “HIPAA and Patient Care: The Role for Professional Judgment,” JAMA 293, no. 14 (2005): 1766–71.Google Scholar
National Institutes of Health, “Blue Ribbon Panel on Conflict of Interest Policies,” June 22, 2004. Report of the Working Group of the Advisory Committee to the Director, National Institutes of Health, at <www.nih.gov/about/ethics_COI_panelreport.pdf> (last visited January 13, 2006).+(last+visited+January+13,+2006).>Google Scholar
See Weiss, , supra note 16.Google Scholar
See Weiss, , supra note 16.Google Scholar
Capitol Hill Watch, “Two Lawmakers Urge Zerhouni to Revise NIH Conflict-of-Interest rules,” Kaiser Daily Health Policy Report April 18, 2005, available at <http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=3&DR_ID=29413> (last visited January 13, 2006).+(last+visited+January+13,+2006).>Google Scholar
See National Institutes of Health, supra note 32.Google Scholar
Eisen, A. and Barry, R. M., “The Absent Professor: Why we Don't Teach Research Ethics and What to do about it,” American Journal of Bioethics 2, no. 4 (2002): 38–49.Google Scholar
Brown, S. and Kalichman, M. W., “Effects of Training in the Responsible Conduct of Research: A Survey of Graduate Students in Experimental Sciences,” Science and Engineering Ethics 4, no. 4 (1998): 487–98.Google Scholar
Bebeau, M. J. and Tohma, S. J., “The Impact of a Dental Ethics Curriculum on Moral Reasoning,” Journal of Dental Education 58, no. 9 (1994): 684–92.Google Scholar